Connect Biopharma Holdings Ltd (CNTB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.65M
Last updated: Nov 17, 2026 at 11:05 AM ET
Connect Biopharma Holdings Ltd (CNTB) Competitors
The companies most similar to Connect Biopharma Holdings are ImageneBio (IMA), Barinthus Biotherapeutics (BRNS) and XBiotech (XBIT). By market cap, Connect Biopharma Holdings ranks 7th of the 13 companies on this page; Corbus Pharmaceuticals Holding (CRBP) is the largest at $69.86M.
Peer Comparison
CNTB's revenue growth of 5667.0% is above the peer median of -1.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Connect Biopharma Holdings (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Barinthus Biotherapeutics plc (BRNS) | $30.23M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| iBio, Inc. Common Stock (IBIO) | $51.55M | N/A | 735.4x | 0.0% | N/A | 975.0% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Biomea Fusion Inc (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Corbus Pharmaceuticals Holding (CRBP) | $69.86M | N/A | 13.9x | 0.0% | -106.7% | -100.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Werewolf Therapeutics Inc (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| Peer median | $42.77M | N/A | 13.9x | 0.0% | -106.7% | -1.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Connect Biopharma Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Barinthus Biotherapeutics plc (BRNS) | Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system... | BRNS competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| iBio, Inc. Common Stock (IBIO) | iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. | IBIO competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Biomea Fusion Inc (BMEA) | Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat... | BMEA competitors |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Corbus Pharmaceuticals Holding (CRBP) | Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target... | CRBP competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Werewolf Therapeutics Inc (HOWL) | Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. | HOWL competitors |
Frequently Asked Questions About CNTB
Who are Connect Biopharma Holdings' main competitors?
The companies most similar to Connect Biopharma Holdings include ImageneBio (IMA), Barinthus Biotherapeutics (BRNS), XBiotech (XBIT), INmune Bio (INMB) and iBio, Inc. Common Stock (IBIO), listed from the closest match.
Who is Connect Biopharma Holdings' biggest competitor?
Corbus Pharmaceuticals Holding (CRBP) is the largest of the similar companies at $69.86M; ImageneBio (IMA) is the closest match by business profile, size, sector and industry.
How does CNTB stock compare with its competitors?
CNTB's P/S is 13.6x against a peer median of 13.9x; its net margin is 0.0% against a peer median of 0.0%.
Which of Connect Biopharma Holdings' competitors pays a higher dividend?
Connect Biopharma Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Connect Biopharma Holdings bigger than its competitors?
No. Connect Biopharma Holdings is 7th by market cap among the 13 companies on this page; the largest is Corbus Pharmaceuticals Holding (CRBP) at $69.86M.
CNTB pages: Overview, Competitors